Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR2 | O15552 | 2/20 | 0.65 |
| ▸ | MME | P08473 | 11/20 | 0.59 |
| ▸ | MMEL1 | Q495T6 | 6/20 | 0.54 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.49 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2314864 | 1.00 | FFAR2 (0.65) | FFAR2MMEMMEL1PSMB8PSMB5 | |
| SCHEMBL2312039 | 1.00 | FFAR2 (0.65) | FFAR2MMEMMEL1PSMB8PSMB5 | |
| SCHEMBL2317534 | 0.92 | MME (0.63) | FFAR2MMEMMEL1PSMB8PSMB5 | |
| SCHEMBL2317537 | 0.92 | MME (0.63) | FFAR2MMEMMEL1PSMB8PSMB5 | |
| SCHEMBL2319102 | 0.91 | FFAR2 (0.68) | FFAR2MMEMMEL1ALDH1A1 | |
| SCHEMBL2319095 | 0.91 | FFAR2 (0.68) | FFAR2MMEMMEL1ALDH1A1 | |
| SCHEMBL2315240 | 0.89 | FFAR2 (0.79) | FFAR2MMEMMEL1PSMB8PSMB5 | |
| SCHEMBL2315245 | 0.89 | FFAR2 (0.79) | FFAR2MMEMMEL1PSMB8PSMB5 | |
| SCHEMBL2315341 | 0.89 | FFAR2 (0.79) | FFAR2MMEMMEL1PSMB8PSMB5 | |
| SCHEMBL2319372 | 0.89 | FFAR2 (0.57) | FFAR2MMEMMEL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011092284-A1 | NOVEL AMINO ACID DERIVATIVES AND THEIR USE AS GPR43 RECEPTOR MODULATORS | EUROSCREEN S.A. (BE) | 2011-08-04 | — | — | WO | claimed |